Final Program - American Society of Gene & Cell Therapy
Final Program - American Society of Gene & Cell Therapy
Final Program - American Society of Gene & Cell Therapy
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Abstract Directory, Thursday, May 16, 2013<br />
Poster Session I, continued<br />
4:00 PM - 6:00 PM<br />
Room: Exhibit Hall C/D<br />
Infectious Diseases and Vaccines<br />
184<br />
Next <strong>Gene</strong>ration TALENs Mediate Eficient Disruption <strong>of</strong><br />
the CCR5 <strong>Gene</strong> in Human HSCs<br />
Nick Llewellyn, Jeffrey C. Miller, John Campo, Colin Exline, Orla<br />
Mulhern, Jill Henley, Jianbin Wang, Dmitry Guschin, Danny Xia,<br />
Irina Ankoudinova, Philip D. Gregory, Lei Zhang, Edward J. Rebar,<br />
Michael C. Holmes, Paula M. Cannon.<br />
185<br />
Enhanced Neutralising Antibody Response to Bovine<br />
Viral Diarrhoea Virus (BVDV) Induced by BVDV DNA<br />
Vaccine Co-Expressing RIG-I Agonist in Cattle<br />
Laila M. El-Attar, Olivia Anstaett, Carole Thomas, Jeremy Luke,<br />
James Williams, Joe Brownlie.<br />
186<br />
Preclinical Safety Evaluation <strong>of</strong> an Antibiotic-Free<br />
LAMP-1 Plasmid Allergy Immunotherapy<br />
Teri L. Heiland, James A. Williams, William G. Hearl.<br />
187<br />
Inhibition <strong>of</strong> HBV Replication through ZFN-Mediated<br />
Disruption <strong>of</strong> cccDNA<br />
Daniel Stone, Nick Weber, Harshana De Silva Feelixge, Keith R.<br />
Jerome.<br />
188<br />
Development <strong>of</strong> Designer Homing Endonucleases for<br />
Inactivation <strong>of</strong> the HIV Provirus<br />
Esther Mintzer, Jordan Jarjour, Andy Scharenberg, Barry Stoddard,<br />
David Baker, Nick Weber, Daniel Stone, Keith R. Jerome.<br />
189<br />
Whole <strong>Cell</strong>-SELEX Derived Anti-CD7 Aptamers for the<br />
Delivery <strong>of</strong> Anti-CCR5 siRNA: A Prohylactic Approach to<br />
HIV <strong>Therapy</strong><br />
Laura Millroy, Daniel Lazar, Makobetsa Khati, Marc S. Weinberg.<br />
190<br />
Capsid Modiied AAV2 Vectors Are Capable <strong>of</strong><br />
<strong>Gene</strong>rating Functional Cytotoxic T <strong>Cell</strong>s in a Prime-<br />
Boost Vaccine Protocol<br />
Brad E. H<strong>of</strong>fman, Irene Zolotukhin, Roland W. Herzog, Ou Cao.<br />
191<br />
The Anti-Genomic (Negative) Strand <strong>of</strong> Hepatitis C<br />
Virus Is Not Targetable by shRNA<br />
Leszek Lisowski, Menashe Elazar, Kirk Chu, Jeffrey S. Glenn, Mark<br />
A. Kay.<br />
192<br />
Development <strong>of</strong> the Oral Universal Type A Inluenza<br />
Vaccine Using Biidobacterium Displaying Inluenza-<br />
M2e Protein<br />
Naoya Morishita, Suzuka Ozaki, Koichi Kitagawa, Chihiro<br />
Shirosaki, Hiroki Saito, Katsumi Shigemura, Masato Fujisawa,<br />
Masato Kawabata, Toshiro Shirakawa.<br />
193<br />
Enzyme Engineering <strong>of</strong> Homing Endonucleases To<br />
Target HBV cccDNA<br />
Nicholas D. Weber, Ryo Takeuchi, Jordan Jarjour, Daniel Stone,<br />
Barry L. Stoddard, Keith R. Jerome.<br />
194<br />
In Vivo Electroporation <strong>of</strong> Minicircle DNA as a Noval<br />
Method <strong>of</strong> Vaccine Delivery<br />
Wenlin Huang, Qingtao Wang, Changchuan Pan, Shijuan Gao, Wei<br />
Jiang.<br />
195<br />
The Potential Therapeutic Role <strong>of</strong> Secreted Antiviral<br />
Entry Inhibitory (SAVE) Peptides Expressed by<br />
Transduced MSCs To Block Viral Replication<br />
Narae Lee, Edith Walker, Wenpeng Li, Lisa Egerer, Dorothee von<br />
Laer, Bruce A. Bunnell, Stephen E. Braun.<br />
Cancer Immunotherapy I<br />
196 Abstract Withdrawn<br />
197<br />
Dual Transgenesis <strong>of</strong> T <strong>Cell</strong>s with a CD44v6-Speciic<br />
CAR and a Suicide <strong>Gene</strong> for the Safe Eradication <strong>of</strong><br />
Myeloid Leukemia and Myeloma<br />
Monica Casucci, Benedetta Nicolis di Robilant, Laura Falcone,<br />
Barbara Camisa, Pietro Genovese, Bernhard Gentner, Claudio<br />
Bordignon, Barbara Savoldo, Fabio Cicieri, Luigi Naldini,<br />
Gianpietro Dotti, Chiara Bonini, Attilio Bondanza.<br />
198<br />
Capitalizing on Epitope Escape To Avoid T <strong>Cell</strong><br />
Fratricide without Compromising Targeting <strong>of</strong> CD56+<br />
Tumors<br />
Denise L. Crossland, Sonny Ang, Simon Olivares, Kirsten Switzer,<br />
Tiejuan Mi, Helen Huls, Laurence J. N. Cooper.<br />
199<br />
Phase II Study <strong>of</strong> FANG (Autologous Tumor <strong>Cell</strong><br />
– GMCSF/pbi-shRNA Furin DNA Plasmid) Vaccine in<br />
Advanced Melanoma<br />
John Nemunaitis, Neil Senzer, Minal Barve, Padmasini Kumar,<br />
Donald D. Rao, Gladice Wallraven, Beena O. Pappen, Jospeh Kuhn,<br />
Peter Beitsch, Robert Steckler, Brian M. Gogel, Walton Taylor,<br />
Phillip B. Maples.<br />
200<br />
Renal <strong>Cell</strong> Tumor-Mediated Reprogramming <strong>of</strong> Natural<br />
Killer <strong>Cell</strong>s by Soluble Immune Modulators<br />
Yue Guan, Purba Singh, Trenae Mann, Christopher B. Chambers,<br />
Donald S. Torry, Andrew Wilber.<br />
Thursday, May 16, 2013<br />
<strong>Final</strong> <strong>Program</strong> SALT LAKE CITY, UTAH May 15–18, 2013<br />
101
Change language